- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
NASDAQ Biotechnology (NBI)Comprehensive information about the NASDAQ Biotechnology index. More information is available in the different sections of the NASDAQ Biotechnology page, such as: historical data, charts, technical analysis and others.
NASDAQ
Currency in USD
4,328.7
+39.1(+0.91%)
Closed
Day's Range
4,275.9
4,369.0
52 wk Range
4,026.4
4,954.8
Day's Range
4,275.94,369.0
52 wk Range
4,026.44,954.8
- Prev. Close
- 4,289.6
- Open
- 4,278.7
- 1-Year Change
- 0.86%
- Volume
- 1
- Average Volume (3m)
- 1
- Day's Range
- 4,275.9-4,369
- 52 wk Range
- 4,026.4-4,954.8
How do you feel today about NBI?
Vote to see community's results!
or- Mesoblast to be Added to Nasdaq Biotechnology Index
- Investing.com
- How do Diagnostic Tool stocks perform in an election year?
- Investing.com
Pro
- Mesoblast to be Added to Nasdaq Biotechnology Index
- Investing.com
- How do Diagnostic Tool stocks perform in an election year?
- Investing.com
Pro
| Name | Last | Chg. % | Vol. | Time | Price | |
|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology | 132.73 | +1.16% | 2M | 132.73+1.16% | 21/12 | |
IBBQ Invesco Nasdaq Biotechnology | 21.60 | +0.84% | 10.46K | 21.60+0.84% | 21/12 |
| Name | Last | Prev. | High | Low | Chg. % | Vol. | Time | Price | |
|---|---|---|---|---|---|---|---|---|---|
HUMA Humacyte Inc | 4.64 | 3.46 | 6.77 | 4.45 | +34.10% | 75.49M | 4.64+34.10% | 21/12 | |
VTRS Viatris Inc | 12.52 | 12.13 | 12.57 | 12.14 | +3.22% | 56.55M | 12.52+3.22% | 21/12 | |
MRNA Moderna Inc | 39.39 | 39.56 | 40.83 | 39.12 | -0.43% | 35.48M | 39.39-0.43% | 21/12 | |
GERN Geron Corporation | 3.49 | 3.66 | 3.685 | 3.455 | -4.64% | 26.32M | 3.49-4.64% | 21/12 | |
GILD Gilead Sciences Inc | 92.57 | 91.09 | 93.29 | 90.71 | +1.62% | 22.53M | 92.57+1.62% | 21/12 |
Top Gainers
| Name | Price |
|---|---|
HUMA Humacyte | 4.64+1.180+34.10% |
IRWD Ironwood | 4.45+0.57+14.69% |
ETNB 89bio | 7.94+0.91+12.94% |
SAGE SAGE Therapeutics | 5.61+0.61+12.20% |
VERV Verve Therapeutics | 5.74+0.58+11.24% |
Top Losers
| Name | Price |
|---|---|
BLUE Bluebird | 8.50-0.7300-7.91% |
GPCR Structure Therapeutics ADR | 27.90-2.07-6.91% |
PRTA Prothena | 15.22-0.79-4.93% |
PHAT Phathom Pharma | 7.45-0.37-4.73% |
LYEL Lyell Immunopharma | 0.613-0.028-4.68% |
Beat the S&P 500
Picked from S&P 500, refined by AI. This strategy studies all 500 stocks, then selects the elite 20 most likely to outperform the market in the next month.
S&P 500 Outperformance+731.2%
Annualised Return+22.6%
Stocks in this strategy
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
People Also Watch
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.